BLOGS WEBSITE

JDRF: Strategic Research Agreements 2015 (Round 3) – Single Project, Multi-Project, and Clinical

JDRF Strategic Research Agreements are designed to provide research funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in Type 1 diabetes research.

The Strategic Research Agreement is a partnership between Investigator(s) and JDRF Scientists to help address roadblocks and accelerate JDRF’s mission through support of cutting-edge scientific investigation.

Strategic Research Agreement Schemes

  • Strategic Agreements: Single-project
  • Strategic Agreements: Multi-project
  • Strategic Agreements: Clinical

Funding

Available funding for the Strategic Research Agreement will be reviewed on a per-application basis. Projects are initially funded for up to 3 years in duration. Support beyond 3 years will be determined based on a detailed scientific review of the accomplishments and future plans of the Project.

Eligibility

Applicants must hold an MD, DMD, DVM, PhD, or equivalent and have a faculty position or equivalent at a college, university, medical school, company, or other research facility.

Applications may be submitted by domestic and foreign non-profit organisations, public and private, such as colleges, universities, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.

Submission Requirements & Due Dates

  • 13 November 2015 – Project Concepts submitted through JDRF’s Project Concept Call in RMS360.
  • Copy of Project Concept forwarded to the Research Branch ASAP.
  • Invited Full Applications (date TBA) must be submitted to the Research Branch for review
  • Full applications to be submitted with the University’s Grant Application Cover Sheet.

Grants Officer: Dr Don McMaster

Email: don.mcmaster@adelaide.edu.au

Further Information

This entry was posted in Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding. Bookmark the permalink.
 

Comments are closed.